Published in Br J Clin Pharmacol on October 01, 1982
Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects. Br J Clin Pharmacol (2006) 1.16
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter? Br J Clin Pharmacol (2013) 1.03
Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians. Br J Clin Pharmacol (1995) 0.99
Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update. Drug Saf (2015) 0.77
Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study. Br J Clin Pharmacol (2015) 0.75
Coronary heart-attacks in East London. Lancet (1975) 8.55
The epidemiology of atherosclerosis among a random sample of clothing workers of different ethnic origins in New York City. I. Prevalence of atherosclerosis and some associated characteristics. J Chronic Dis (1957) 1.82
The systemic blood pressure in a rural West African community. West Afr Med J (1960) 1.32
Studies of quinidine plasma levels and rate of decline following cessation of quinidine administration. Am Heart J (1954) 1.27
Some medical problems of immigration into Britain. Electrocardiographic changes in West Indians. Proc R Soc Med (1963) 1.03
Racial differences in drug metabolizing ability: a study with antipyrine in the Sudan. Clin Pharmacol Ther (1978) 0.99
Ethnic differences in mortality from ischemic heart disease: a study of migrant and native populations. J Chronic Dis (1978) 0.92
Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital. Clin Pharmacol Ther (1973) 1.64
Human liver microsomal drug metabolism. Biochem Pharmacol (1970) 1.24
Chloroquine-resistant Plasmodium falciparum and malaria in Africa. Trans R Soc Trop Med Hyg (1977) 1.09
The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1981) 1.09
Medicinal arsenic and internal malignancies. Br J Cancer (1982) 1.07
The practical and therapeutic implications of chloroquine-induced itching in tropical Africa. Afr J Med Med Sci (1977) 1.01
Use and misuse of 4-aminoquinoline antimalarials in tropical Africa and re-examination of itch reaction to these drugs. Trop Doct (1981) 0.95
Total T lymphocytes in primary bronchial carcinoma. Thorax (1977) 0.79
Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria. East Afr Med J (1977) 0.76
Chloroquine and enzymes. West Afr J Pharmacol Drug Res (1976) 0.75
Diminished extractable spectrin in the erythrocytes of a patient with 'sporadic' hereditary spherocytosis. Acta Haematol (1986) 0.75